🇸🇪

HNSA.ST| Hansa Biopharma

Healthcare•Biotechnology•SEK Currency

Dividend Yield
0.00%
Forward annual yield
Growth Streak
0 Years
Consecutive increases
Annual Payout
SEK 0.00
SEK per share
Payout Ratio
—
Earnings payout
5Y Growth (CAGR)
—
5-Year dividend CAGR
Ex-Dividend Date
Annual / Semi-Annual
Next / Recent ex-date

Hansa Biopharma (HNSA.ST) pays an annualized forward dividend of SEK 0.00 per share in SEK, representing a forward yield of 0.00%.

Historical Dividend Payouts(HNSA.ST)

Recent cash distributions, declared payout dates, and distribution track record.

Detailed distribution payments are updated regularly. Hansa Biopharma distributes an annualized rate of SEK 0.00 per share on a annual / semi-annual schedule.

Dividend Reinvestment (DRIP) Calculator

Simulate compound dividend reinvestment returns with HNSA.ST.

Initial InvestmentSEK 10,000
Monthly ContributionSEK 250/mo
Starting Dividend Yield3.50%
Annual Dividend Growth (CAGR)6.0%
Annual Share Price Growth5.0%
Investment Horizon15 Years
Portfolio Value
SEK 148,150
Annual Dividend
SEK 10,172/yr
Monthly Income
SEK 848/mo
Capital BreakdownYear 15 Projection
Contributions: SEK 55,000
Dividends & Growth: +SEK 93,150
YearBalanceAnnual DividendMonthly Cash Flow
Year 5SEK 33,361+SEK 1,226+SEK 102/mo
Year 10SEK 72,940+SEK 3,729+SEK 311/mo
Year 15SEK 148,150+SEK 10,172+SEK 848/mo

Similar Healthcare Dividend Stocks

View all Healthcare →

Benchmark Comparison: HNSA.ST vs. Top Dividend ETFs

Compare HNSA.ST's yield and dividend growth streak against broad market dividend funds.

Explore all Dividend ETFs →

Frequently Asked Questions about Hansa Biopharma (HNSA.ST)

How many consecutive years has Hansa Biopharma (HNSA.ST) increased its dividend?

Hansa Biopharma (HNSA.ST) has increased its annual dividend payout for 0 consecutive years, placing it in the Dividend Contender tier.

What is Hansa Biopharma's current dividend yield and payout?

As of recent market updates, Hansa Biopharma offers a forward dividend yield of 0.00% with an estimated annual payout of SEK 0.00 per share in SEK.

Is Hansa Biopharma (HNSA.ST) a Dividend Aristocrat or King?

With a 0-year streak, Hansa Biopharma is classified as a Dividend Contender, working toward Aristocrat status (25+ years).

How does dividend reinvestment (DRIP) work for HNSA.ST?

A Dividend Reinvestment Plan (DRIP) allows you to automatically reinvest cash dividends from Hansa Biopharma into additional shares or fractional shares, compounding your investment value over time.